Target intelligence / Profile preview

microRNA 5702 (MIR5702)

Target
MIR5702
Molecular classification
microRNA, Non-coding RNA, Small RNA molecule
01

Overview

microRNA 5702 (MIR5702) is a small, non-coding RNA molecule found in the human genome. MicroRNAs, including MIR5702, are transcribed as primary transcripts and processed through well-defined enzymatic steps (Drosha, Dicer) to generate mature ~22 nucleotide RNAs that associate with Argonaute proteins in the RNA-induced silencing complex (RISC). They regulate gene expression by binding complementary sequences in target mRNAs—typically in the 3' untranslated region—leading to translational repression or mRNA degradation. The specific biological role, disease associations, and pharmacological relevance of MIR5702 remain poorly characterized in public databases and published literature as of September 2025. While some microRNAs act as oncogenes or tumor suppressors, no published data currently clarify MIR5702's direct involvement in cellular pathways, disease states, or its utility as a drug target.

Other names
hsa-mir-5702MIR5702microRNA 5702
02

Mechanism of action

No drugs are known to target MIR5702 specifically. General mechanisms of microRNAs: Bind to complementary sequences in mRNAs via the "seed" region (often at the 3' UTR), inhibiting translation or inducing mRNA degradation.

03

Biological functions

Regulation of gene expression (post-transcriptional gene silencing)RNA silencing
04

Disease associations

CancerCell proliferationApoptosisImmune response
05

Safety considerations

Off-target gene regulationImmune activationDelivery challenges
06

Biomarkers

MicroRNA expression profiles can sometimes serve as biomarkers in disease contexts, mainly in cancer

Beyond the preview

Go deeper on microRNA 5702 (MIR5702).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 5702 (MIR5702).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call